VEA
ITOS
Virtus ETF Advisers’s iTeos Therapeutics ITOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,948
| Closed | -$68.7K | – | 475 |
|
|
2024
Q4 | $68.7K | Buy |
8,948
+3,293
| +58% | +$25.3K | 0.03% | 389 |
|
|
2024
Q3 | $57.7K | Buy |
5,655
+101
| +2% | +$1.03K | 0.03% | 438 |
|
|
2024
Q2 | $82.4K | Sell |
5,554
-2,492
| -31% | -$37K | 0.04% | 393 |
|
|
2024
Q1 | $110K | Sell |
8,046
-550
| -6% | -$7.5K | 0.06% | 353 |
|
|
2023
Q4 | $94.1K | Buy |
8,596
+1,530
| +22% | +$16.8K | 0.06% | 388 |
|
|
2023
Q3 | $77.4K | Sell |
7,066
-707
| -9% | -$7.74K | 0.05% | 366 |
|
|
2023
Q2 | $103K | Buy |
7,773
+2,991
| +63% | +$39.6K | 0.06% | 368 |
|
|
2023
Q1 | $65.1K | Sell |
4,782
-1,838
| -28% | -$25K | 0.04% | 412 |
|
|
2022
Q4 | $129K | Buy |
6,620
+792
| +14% | +$15.5K | 0.07% | 389 |
|
|
2022
Q3 | $111K | Buy |
5,828
+38
| +0.7% | +$724 | 0.04% | 409 |
|
|
2022
Q2 | $119K | Buy |
5,790
+1,629
| +39% | +$33.5K | 0.04% | 386 |
|
|
2022
Q1 | $134K | Sell |
4,161
-251
| -6% | -$8.08K | 0.06% | 244 |
|
|
2021
Q4 | $205K | Sell |
4,412
-3,319
| -43% | -$154K | 0.08% | 200 |
|
|
2021
Q3 | $209K | Sell |
7,731
-403
| -5% | -$10.9K | 0.09% | 260 |
|
|
2021
Q2 | $209K | Sell |
8,134
-1,958
| -19% | -$50.3K | 0.09% | 315 |
|
|
2021
Q1 | $345K | Buy |
10,092
+176
| +2% | +$6.02K | 0.15% | 210 |
|
|
2020
Q4 | $335K | Buy |
+9,916
| New | +$335K | 0.14% | 181 |
|